JP2001505407A5 - - Google Patents

Download PDF

Info

Publication number
JP2001505407A5
JP2001505407A5 JP1998508239A JP50823998A JP2001505407A5 JP 2001505407 A5 JP2001505407 A5 JP 2001505407A5 JP 1998508239 A JP1998508239 A JP 1998508239A JP 50823998 A JP50823998 A JP 50823998A JP 2001505407 A5 JP2001505407 A5 JP 2001505407A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998508239A
Other languages
English (en)
Japanese (ja)
Other versions
JP4161084B2 (ja
JP2001505407A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/013945 external-priority patent/WO1998005783A1/en
Publication of JP2001505407A publication Critical patent/JP2001505407A/ja
Publication of JP2001505407A5 publication Critical patent/JP2001505407A5/ja
Application granted granted Critical
Publication of JP4161084B2 publication Critical patent/JP4161084B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP50823998A 1996-08-07 1997-08-07 腫瘍壊死因子関連リガンド Expired - Lifetime JP4161084B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US2354196P 1996-08-07 1996-08-07
US60/023,541 1996-08-07
US2851596P 1996-10-18 1996-10-18
US60/028,515 1996-10-18
US4082097P 1997-03-18 1997-03-18
US60/040,820 1997-03-18
PCT/US1997/013945 WO1998005783A1 (en) 1996-08-07 1997-08-07 A tumor necrosis factor related ligand

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007028621A Division JP4411330B2 (ja) 1996-08-07 2007-02-07 腫瘍壊死因子関連リガンド

Publications (3)

Publication Number Publication Date
JP2001505407A JP2001505407A (ja) 2001-04-24
JP2001505407A5 true JP2001505407A5 (https=) 2005-04-07
JP4161084B2 JP4161084B2 (ja) 2008-10-08

Family

ID=27362110

Family Applications (3)

Application Number Title Priority Date Filing Date
JP50823998A Expired - Lifetime JP4161084B2 (ja) 1996-08-07 1997-08-07 腫瘍壊死因子関連リガンド
JP2007028621A Expired - Lifetime JP4411330B2 (ja) 1996-08-07 2007-02-07 腫瘍壊死因子関連リガンド
JP2009080644A Withdrawn JP2009183294A (ja) 1996-08-07 2009-03-27 腫瘍壊死因子関連リガンド

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2007028621A Expired - Lifetime JP4411330B2 (ja) 1996-08-07 2007-02-07 腫瘍壊死因子関連リガンド
JP2009080644A Withdrawn JP2009183294A (ja) 1996-08-07 2009-03-27 腫瘍壊死因子関連リガンド

Country Status (25)

Country Link
EP (2) EP0956351B1 (https=)
JP (3) JP4161084B2 (https=)
KR (1) KR100543730B1 (https=)
CN (2) CN101024831A (https=)
AT (1) ATE307204T1 (https=)
AU (1) AU736289B2 (https=)
BG (1) BG64779B1 (https=)
BR (1) BR9711046A (https=)
CA (1) CA2262756C (https=)
CZ (1) CZ297387B6 (https=)
DE (1) DE69734397T2 (https=)
DK (1) DK0956351T3 (https=)
EA (1) EA003187B1 (https=)
EE (1) EE05276B1 (https=)
ES (1) ES2251737T3 (https=)
HU (1) HU226787B1 (https=)
IL (1) IL128407A (https=)
IS (1) IS2606B (https=)
NO (2) NO326967B1 (https=)
NZ (1) NZ334107A (https=)
PL (1) PL188102B1 (https=)
SI (1) SI0956351T1 (https=)
SK (1) SK288012B6 (https=)
TR (1) TR199900903T2 (https=)
WO (1) WO1998005783A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011791A2 (en) * 1997-09-05 1999-03-11 University Of Washington Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
EP1021542B1 (en) * 1997-10-10 2009-03-04 Genentech, Inc. Apo-3 ligand
DE19829550C1 (de) * 1998-07-02 2000-01-27 Bosch Gmbh Robert Vorrichtung zum Verbinden von Bauteilen
JP5550799B2 (ja) * 1999-01-15 2014-07-16 バイオジェン・アイデック・エムエイ・インコーポレイテッド Tweakのアンタゴニストおよびtweakレセプターのアンタゴニスト、ならびに免疫学的障害を処置するためのこれらの使用
US6994976B1 (en) 1999-11-19 2006-02-07 Tittle Thomas V Tr3-specific binding agents and methods for their use
CA2391530A1 (en) * 1999-11-19 2001-05-25 Thomas V. Tittle Tr3-specific binding agents and methods for their use
EP1239869B1 (en) * 1999-12-20 2013-08-28 Immunex Corporation Tweak receptor
US6727225B2 (en) 1999-12-20 2004-04-27 Immunex Corporation TWEAK receptor
US7495086B2 (en) 1999-12-20 2009-02-24 Immunex Corporation TWEAK receptor
JP2004500844A (ja) 2000-05-08 2004-01-15 バイオジェン インコーポレイテッド Tweakアゴニストおよび血管形成因子を使用する、新血管新生を促進するための方法
US7208151B2 (en) 2001-09-12 2007-04-24 Biogen Idec Ma Inc. Tweak receptor agonists as anti-angiogenic agents
EA011607B1 (ru) 2002-04-09 2009-04-28 Байоджен Айдек Ма Инк. Способ лечения заболеваний, связанных с tweak
EP2311867A1 (en) * 2002-10-29 2011-04-20 Anaphore, Inc. Trimeric binding proteins for trimeric cytokines
EP2529619B1 (en) 2005-02-17 2015-09-23 Biogen MA Inc. Treating neurological disorders
JP5339901B2 (ja) 2005-05-10 2013-11-13 バイオジェン・アイデック・エムエイ・インコーポレイテッド 炎症傷害の処置および評価
DK1888113T3 (da) 2005-05-27 2014-09-01 Biogen Idec Inc Tweak-bindende antistoffer
WO2006138219A2 (en) 2005-06-13 2006-12-28 Biogen Idec Ma Inc. Methods of diagnosis / prognosis of inflammatory conditions
US8093006B2 (en) 2009-04-02 2012-01-10 Hoffmann-La Roche Inc. Antibodies against human tweak and uses thereof
KR101584416B1 (ko) 2010-10-05 2016-01-13 에프. 호프만-라 로슈 아게 인간 tweak에 대한 항체 및 그의 용도
WO2013150043A1 (en) 2012-04-05 2013-10-10 F. Hoffmann-La Roche Ag Bispecific antibodies against human tweak and human il17 and uses thereof
CN110023499A (zh) * 2016-10-24 2019-07-16 拜欧亿思有限公司 肿瘤坏死因子-α(TNF-α)结合适配体及其治疗用途
WO2019203904A1 (en) * 2018-04-20 2019-10-24 Academia Sinica Tnf-targeting aptamers and uses thereof for treatment or diagnosing tnf-related inflammatory diseases
JP2024516548A (ja) 2021-04-08 2024-04-16 ジョスリン ダイアビーティス センター インコーポレイテッド 腎機能低下の診断及び予測の方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5176996A (en) 1988-12-20 1993-01-05 Baylor College Of Medicine Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use
US5256775A (en) 1989-06-05 1993-10-26 Gilead Sciences, Inc. Exonuclease-resistant oligonucleotides
IE902820A1 (en) 1989-08-07 1991-02-27 Merck & Co Inc Peptide inhibitors of human papilloma virus protein binding¹to retinoblastoma gene proteins
US5264564A (en) 1989-10-24 1993-11-23 Gilead Sciences Oligonucleotide analogs with novel linkages
CA2077322A1 (en) 1991-09-04 1993-03-05 Allen I. Oliff Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins

Similar Documents

Publication Publication Date Title
JP2001502561A5 (https=)
JP2001502191A5 (https=)
JP2000506415A5 (https=)
JP2000514457A5 (https=)
JP2000514264A5 (https=)
JP2001500744A5 (https=)
JP2000517115A5 (https=)
JP2000517499A5 (https=)
JP2000509578A5 (https=)
JP2000510014A5 (https=)
JP2000507766A5 (https=)
JP2001505863A5 (https=)
JP2000516487A5 (https=)
JP2000513390A5 (https=)
JP2001503573A5 (https=)
JP2001503736A5 (https=)
JP2000511510A5 (https=)
JP2001503031A5 (https=)
JP2001503459A5 (https=)
JP2001504980A5 (https=)
JP2001503324A5 (https=)
JP2001501286A5 (https=)
JP2000510882A5 (https=)
JP2000505872A5 (https=)
JP2001500541A5 (https=)